Krishna Institute of Medical Sciences Limited

B. Bhaskar Rao

VISIONARY BEHIND KIMS

Rs. 45,000

entre” in Hyderabad with 50 beds and performed heart surgeries at an unimaginable low cost of just Rs. 45,000 only. Dr. Rao never turned away any patient from the hospital for want of money. The brand “Krishna

rs,

tions before taking charge of Strategy & Marketing for the Group in 2015. In a short span of 5 years, KIMS expanded and opened five additional units (Kondapur, Vizag, Anantapur, Ongole, and Kurnool). S

rs 6

h as Financial counseling tool which uses AI to help patients with surgery costings among many others 6 Private & Confidential BOARD OF DIRECTORS Dr. Bhaskara Rao Bollineni Managing Director Dr. Abhinay

3.3%

ani Independent Director 7 Private & Confidential SHAREHOLDING PATTERN - 30TH JUNE, 2022 Retail, 3.3% Retail Pre IPO, 9.0% Clearing Members, 0.0% FII, 8.4% DII, 20.8% Promoter & Promoter Group

9.0%

r 7 Private & Confidential SHAREHOLDING PATTERN - 30TH JUNE, 2022 Retail, 3.3% Retail Pre IPO, 9.0% Clearing Members, 0.0% FII, 8.4% DII, 20.8% Promoter & Promoter Group, 38.8% As on 30th Jun

0.0%

al SHAREHOLDING PATTERN - 30TH JUNE, 2022 Retail, 3.3% Retail Pre IPO, 9.0% Clearing Members, 0.0% FII, 8.4% DII, 20.8% Promoter & Promoter Group, 38.8% As on 30th June 2022 Top Shareholders -

8.4%

DING PATTERN - 30TH JUNE, 2022 Retail, 3.3% Retail Pre IPO, 9.0% Clearing Members, 0.0% FII, 8.4% DII, 20.8% Promoter & Promoter Group, 38.8% As on 30th June 2022 Top Shareholders - DII / FII

20.8%

N - 30TH JUNE, 2022 Retail, 3.3% Retail Pre IPO, 9.0% Clearing Members, 0.0% FII, 8.4% DII, 20.8% Promoter & Promoter Group, 38.8% As on 30th June 2022 Top Shareholders - DII / FII Share Holder

38.8%

Retail Pre IPO, 9.0% Clearing Members, 0.0% FII, 8.4% DII, 20.8% Promoter & Promoter Group, 38.8% As on 30th June 2022 Top Shareholders - DII / FII Share Holder Promoter General Atlantica IC

38.84%

sset Management Goldman Sachs No of Shares Share Holding % Category 31,086,304 13,796,898 38.84% 17.24% 1,939,393 6,988,985 4,754,635 1,274,632 884,552 477,867 1,755,310 1,

17.24%

agement Goldman Sachs No of Shares Share Holding % Category 31,086,304 13,796,898 38.84% 17.24% 1,939,393 6,988,985 4,754,635 1,274,632 884,552 477,867 1,755,310 1,523,107

2.42%

635 1,274,632 884,552 477,867 1,755,310 1,523,107 922,676 428,920 296,327 2.42% 8.73% 5.94% 1.59% 1.11% 0.60% 2.19% 1.90% 1.15% 0.54% 0.37% DII DII DII DII DII FII

“Best Super-Specialty Hospital in Telangana National Quality Excellence Awards 2020 Only Hospital in Telangana to get NABH Accredition for Emergency Department 2021 Ranked No.1 in Hyderabad for Cardiology, Neurosciences, Nephrology & Emergency Times Health Survey Times of India 12 Private & Confidential CONSISTENT PERFORMER OVER 2 DECADES (Rupees in Millions) 16,711 5,217*** CAGR: 27.7% 11,287 4,280 1,311 CAGR: 32.7% 2,412 5,008 1,312 773 42 317 2010 No.”

“1,961 mn), which will be deployed for ongoing/upcoming projects.”

VISION

1

VISION

To be the most preferred healthcare services brand by providing affordable care and best clinical outcomes to patients. And to be the best place to work for doctors and employees. S T N ATIE P Most Preferred Healthcare Provider DOCTORS EMPLOYEES INVESTO RS Affordable Quality Care Best-in-Class Facilities Patient Centric Systems & Processes Clinical Outcome Driven Excellence Latest Medical Technology Strong Academics & Research Oriented Enriching Atmosphere Collaborative Culture Growth Driven Career Approach Transparent Governance Strong Operational Performance Consistent Growth 2 Private & Confidential MULTI SPECIALTY CARE Brain • Neurology • Neurosurgery • Psychiatry • Neuro Rehabilitation Heart • Cardiology • Cardiac Surgery • Vascular Surgery • Heart Transplant • Cardio Rehabilitation Lung • Pulmonology • Interventional Pulmonology • Thoracic surgery • Lung Transplant ENT • Ear • Nose • Throat • Head and Neck Surgery Eyes • Ophthalmology Gastro Intestinal Tract • Medical Gastroenter